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OUTBREAK INVESTIGATIONSP 13-1
SPOTS AND DOTS: WHEN OUTBREAK INVESTIGATION MEETS “REALITY”
Paul Anantharajah Tambyah. Department of Medicine, National University
of Singapore, Singapore
Measles is an important vaccine preventable illness that unfortunately has
re-emerged in recent years for a variety of reasons including anxiety about
vaccination, inadequate vaccine regimes in many countries which still used a
one dose regime as well as the limitations of currently available MMR
vaccines. It is highly transmissible as an airborne disease and can have
atypical presentations in immunocompromised children and adults. It can
spread rapidly in naı¨ve populations and have a serious impact with a
significant morbidity and even mortality. Outbreaks in institutions are not
unknown and present many unique challenges.
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WHEN IS AN OUTBREAK NOT AN OUTBREAK?
Robert A. Weinstein, M.D. Cook County Hospital and Rush University Medical
Center, United States
The seven major steps in outbreak investigation begin with establishing the
existence of an outbreak, i.e., has an outbreak actually occurred; followed by
verifying thediagnoses; doing a case count; orienting data into time, place, and
person; determining the size of the population at risk; developing hypotheses
about the causal factors that led to theoutbreak; and testing those hypotheses.
A key and powerful tool in outbreak evaluation is the epidemic curve from
which many aspects of the epidemiology of the events can be inferred.
Testing causation hypotheses often depends on a case-control study and
increasingly on use of advanced molecular diagnostics to compare outbreak
isolates.
In many instances, 11% in one study, this step-wise approach discloses that
apparent outbreaks are pseudo-epidemics. The most common problems that
have led to pseudo-epidemics have been specimen processing errors,
surveillance artifacts, or clinical misdiagnoses.SP 13-3
MYCOBACTERIUM ABSCESSUS SUBSPECIES MASSILIENSE: AN EMERGING
HEALTHCARE ASSOCIATED PATHOGEN
Aristine Cheng a,b, Wang-Huei Sheng b, Yhu-Chering Huang c, Hsin-
Yun Sun b, Yu-Chung Chuang b, Mei-Lin Chen b, Ying-Chieh Liu b, Yi-
Tzu Tsai b, Po-Ren Hsueh b, Chien-Ching Hung b, Yee-Chun Chen b, Shang-
Chwen Chang b. aNational Taiwan University Hospital, Hsinchu Branch,
Hsinchu City, Taiwan; bNational Taiwan University Hospital, Main Branch,
and National Taiwan College of Medicine, Taipei, Taiwan; cChang Gung
Medical Hospital and Chang Gung University College of Medicine, Taoyuan,
Taiwan
Reports regarding human infections by Mycobacterium abscessus subspecies
massiliense, also known as M. abscessus subspecies bolletii, a subspecies of
the rapidly growing mycobacteria, M. abscessus, have increased since it was
first named in 2004. This emerging pathogen is likely to be under-recognized
since it cannot be identified by conventional methods. However, many mo-
lecular-based studies indicate that this entity is clinically important, highly
resistant to disinfectants, multiply drug resistant, perhaps more transmis-
sible and virulent than M. abscessus sensu stricto. Unusually, a single strain
of M. abscessus subspecies massiliense (BRA 100) has been responsible for an
epidemic of post-surgical infections in Brazil with at least 2032 notified cases
in 63 hospitals across seven regions reported between 2004 and 2010. The
same subspecies has also caused widespread respiratory outbreaks among
cystic fibrosis cohorts in the United States and the United Kingdom. Notably,
high genetic relatedness between these intercontinental outbreak strains, in
contrast to the diversity of environmental NTM, suggest that they may be
more transmissible, whether from a common source, as in soft tissue infec-
tions or from patient-to-patient (directly or indirectly as perhaps in respira-
tory outbreaks). Similarly in Taiwan, outbreaks of post-procedural infectionsby M. abscessus subspecies massiliense, with a seemingly predominant strain
(TPE 101) have emerged.
This lecture reviews the global and local epidemiology of this emerging
healthcare associated pathogen.
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IT COMES WITH WATER
Anucha Apisarnthanarak, M.D. Thammasat University Hospital, Thailand
The complexity of modern healthcare facilities and increasing proportion of
immunologically vulnerable patients make prevention of healthcare-associ-
ated waterborne infections a high priority. Several factors make hospital
buildings suitable for colonization with bacteria and molds: large, complex
water systems with areas of low flow predispose to stagnation and biofilm
formation; water temperatures that are optimal for healthcare use may also
be ideal for bacterial growth. Nursing staff should pay special attention to
children and immunosuppressed patients in terms of tap-water exposure and
also their personal hygiene, and should regularly use sterile water for rinsing/
cleaning devices. In this session, I will discuss the outbreak associated with
water-borne infections in healthcare setting in non-disaster and disaster
related situation. Their preventive measures will also be discussed.SYMPOSIUM 14 (SP 14)
CURRENT LABORATORYMETHODS FOREPIDEMIOLOGICAL INVESTIGATION
DURING NOSOCOMIAL OUTBREAKSP 14-1
LABORATORY METHODS TO SUPPORT EPIDEMIOLOGICAL
INVESTIGATIONS DURING OUTBREAKS
Allen C. Cheng. Infection Prevention and Healthcare Epidemiology Unit,
Alfred Health, Department of Epidemiology and Preventive Medicine,
Monash University, Australia
Typing of bacterial species may be useful to infer transmission, just as
fingerprinting may help place suspects at the scene of a crime. The choice of
method to distinguish between bacterial strains depends on the degree of
resolution required, the resources available and the implications for control
measures. Issues can arise when outbreaks involve the horizontal trans-
mission of genetic material, rather than organisms.
An ideal typing method would be cheap, rapid, reproducible and comparable
between labs, and widely available. For most organisms, older phenotypic
methods to discriminate between strains have generally been supplanted by
genotypic methods. Many genotypic methods exist that distinguish between
strains on the basis of genetic variation either directly (based on sequences)
or indirectly (based in binding to restriction enzymes). However, these
methods must be considered in the context of the background genetic
diversity of the organism, and the reproducibility between laboratories.
The advent of rapid whole genome sequencing at low cost has revolutionized
this field, by providing unprecedented typing resolution and reliability,
although some issues remain in bioinformatics capacity. However, diagnostic
tests that no longer rely on the isolation of an organism in culture may
paradoxically hamper outbreak investigations.SP 14-2
MALDI-TOF MS-BASED SPECIES IDENTIFICATION AND TYPING
APPROACHES IN MYCOBACTERIA
Shang-Chen Hsieh a, Chih-Cheng Su b, Jang-Jih Lu a,c, Hsin-Chih Lai a,c,*.
aGraduate Institute of Medical Biotechnology and Laboratory Science,
College of Medicine, Chang-Gung University, No. 259, Wenhua 1st Rd.,
Gueishan Township, Taoyuan, Taiwan; bInstitute of Microbiology and
Immunology, National Yang-Ming University, No. 155, Sec. 2, Linong St.,
Taipei, Taiwan; cDepartment of Laboratory Medicine, Chang Gung Memorial
Hospital at Linkou, Taoyuan, Taiwan
Rapid and accurate discrimination between non-tuberculosis mycobacteria
(NTM) are essential for appropriate therapeutic management and timely
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time consuming and labor intensive by traditional bacteriological methods.
From our previous report [Yi et al., (1998) Use of Fluorescein Labelled
Antibody and Fluorescence Activated Cell Sorter for Rapid Identification of
Mycobacterium species. Biochem. Biophy. Res. Commu. 250: 403e408.], we
have used Flow Cytometry for rapid identification of Mycobacterium species.
However, identification of Mycobacterium to the species level can be
achieved only depending on the availability of species-specific antibody.
In this presentation, a rapid method involving intact cell mass spectrometry
(ICMS) is presented that shows promise for identification, typing and discrim-
ination of NTM species. In ICMS, cells from a bacterial colony are emulsified in a
chemical matrix, added to a sample probe, dried and analysed by matrix-
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOF-MS). This technique analyses proteins from intact and disrupted bacteria
yielding spectra consisting of 16 peaks from 5000 to 17500, which represent the
mass:charge (m:z) ratios. Each peak corresponds to a molecular fragment
released from the cell surface during laser desorption. Specimens can be
prepared in a few seconds from plate cultures and a spectrum can be obtained
within 10 min. Our results show that MALDI-TOF-MS is applicable for rapid
identification and differentiation of NTM, and thus shows its potential for
clinical NTM identification, or for epidemiological studies.SP 14-3
WHOLE-GENOME MAPPING: A NEW PARADIGM IN STRAIN-TYPING
TECHNOLOGY
Yangsoon Lee, MD, PhD. Department of Laboratory Medicine, Hanyang
Universisty College of Medicine, Hanyang University Seoul Hospital, Seoul,
Republic of Korea
Clinical microbiology is a discipline that focuses primarily on the rapidly
characterizing pathogen samples to direct the management of infected
individual patients and to monitor the epidemiology of infectious disease. A
brief overview of current practice through reviewing some recent articles
has focused on three essential tasks, and also outlined the potential of
sequencing technology to deliver the following key diagnostic information in
the clinical microbiology laboratory: identification of species, antimicrobial
resistance and presence of virulence determinants and strain typing to
detect outbreaks and support surveillance.
DNA sequencing is a powerful method to unravel genetic diversity of
microorganisms. Invention of next generation sequencing (NGS) which
enables massive and cost-effective DNA sequencing has revolutionized the
modern microbiology. Whole-genome sequencing yields all of the available
DNA information content on isolates in a single rapid step. The result
contains all of the data that are currently used for diagnostic and typing
needs, even though how to interpret the data is unknown sometimes.
However, the genome also includes vast amount of additional data that are
currently unavailable for routine processing, thus opening the prospect for
large-scale research into pathogen genotype-phenotype associations from
routinely collected data. High-throughput methods using NGS are evolutio-
nising bacterial genomics, providing sufficient resolution potentially to
determine which cases within temporo-spatial clusters are likely to be
related. With the advent of rapid sequencers, sources of outbreaks have
been identified in clinically relevant timescales, demonstrating the potential
of NGS to transform infection control practice. Genome sequences poten-
tially provide a high-resolution, accurate and reproducible means for
relating organisms. Sequencing can also rapidly provide a clear understand-
ing of the origins of a local outbreak. Examples of the effectiveness of whole
genome analysis for unraveling the origins and dispersal of pathogens at
regional and global scales have recently been published. Herein, the
recently published aritcles will be reviewed at this time.
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RAPID DIAGNOSIS FOR INFECTION CONTROLSP 15-1
MOLECULAR DIAGNOSIS OF DRUG RESISTANCE IN MYCOBACTERIUM
TUBERCULOSIS
Wen-Chun Yen a, Yu-Han Tsai a, Chia-Jung Chiang b, Ruwen Jou c,
Po-Liang Lu d, Hsin-Hui Huang a, Tsung Chain Chang a. aDepartment of
Medical Laboratory Science and Biotechnology, National Cheng Kung
University, Tainan, Taiwan; bChest Hospital, Ministry of Health and
Welfare, Tainan, Taiwan; cReference Laboratory of Mycobacteriology,
Center for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan;
dKaohsiung Medical University Hospital, Kaohsiung, Taiwan
Tuberculosis (TB) is caused by Mycobacterium tuberculosis complex (MTBC);
the disease is an important public health problem worldwide. Although the
global incidence of TB is decreasing, multidrug-resistant TB (MDR-TB) and
extensively drug-resistant TB (XDR-TB) are increasing. The conventional
method of drug susceptibility testing of MTBC takes 3 weeks. The aim of this
study was to detect point mutations in genes of MTBC conferring resistance
to the first and second line drugs [rifampin (RMP), isoniazid (INH), ethambutol
(EMB), streptomycin (SM), ofloxacin (OFX), kanamycin (KA), capreomycin
(CAP), and amikacin (AM)] in positive cultures of Mycobacterial Growth Indica-
tor Tube (MGIT). The method consisted of multiplex PCR (13 pairs of primers)
amplification of the relevant genes, followed by hybridization of the digoxige-
nin-labeled PCR products to probes immobilized on a nylon array. A total of
1426 positive MGIT cultures were analyzed. The sensitivities of the array
(based on patient number) were 91.7% (RMP), 88.9% (INH), 100% (EMB),
82.4% (SM), 100% (OFX), 100% (KA), 50.0% (CAP) and 100% (AM), respectively;
while the specificities were respectively 98.9% (RMP), 99.4% (INH), 99.5%
(EMB), 100% (SM), 100% (OFX), 100% (KA), 99.0% (CAP) and 99.5% (AM). The pos-
itive predictive values were 91.7% (RMP), 97.0% (INH), 92.9% (EMB), 100% (SM),
100% (OFX), 100% (KA), 33.3% (CAP) and 66.7% (AM), respectively; while the
negative predictive values were respectively 98.7% (RMP), 97.7% (INH), 100%
(EMB), 98.4% (SM), 100% (OFX), 100% (KA), 99.5% (CAP) and 100% (AM). In
conclusion, the array can effectively detect gene mutations causing drug
resistance to some important first and second line anti-TB antibiotics in posi-
tive MGIT cultures, except CAP, in a working day.SP 15-2
RAPID DIAGNOSTICS FOR SYPHILIS: AN OVERVIEW OF TEST
PERFORMANCE AND INTRODUCTION
Xiang-Sheng Chen a,*, Yue-Ping Yin a, Rosanna Peeling b. aNational Center
for Sexually Transmitted Disease Control, Chinese Academy of Medical
Sciences & Peking Union Medical College Institute of Dermatology, China;
bLondon School of Hygiene and Tropical Medicine, China
Syphilis remains a major public health problem in many low-income
countries that have limited capacity for laboratory testing, which tradition-
ally relies on use of a non-treponemal test for screening, followed by
confirmation of reactive sera using a treponemal test. However, traditional
tests are usually limited by needs of serum or plasma preparation,
equipment, skilled technician, and electricity. The development of rapid
diagnostics for syphilis (rapid syphilis tests) provides an opportunity to scale
up syphilis screening in many settings where traditional testing is unavai-
lable. Several formats of rapid syphilis tests including single rapid trepo-
nemal test, combined treponemal and non-treponemal test, and dual HIV-1/
2 and treponemal test are commercially available and more are in the
pipeline. Some of these tests have been independently evaluated for their
performance in terms of sensitivity and specificity at qualified laboratories
in multiple sites and showed high performance and favorable operational
characteristics. Based on evidence from evaluation studies, many countries
have changed their policies to adopt syphilis testing with rapid syphilis test
into their screening programmes to improve intervention of syphilis among
